BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28350257)

  • 1. Intrahepatic mass-forming cholangiocarcinoma and solitary hypovascular liver metastases: is the differential diagnosis using diffusion-weighted MRI possible?
    Kovač JD; Galun D; Đurić-Stefanović A; Lilić G; Vasin D; Lazić L; Mašulović D; Šaranović Đ
    Acta Radiol; 2017 Dec; 58(12):1417-1426. PubMed ID: 28350257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.
    Park HJ; Kim YK; Park MJ; Lee WJ
    Abdom Imaging; 2013 Aug; 38(4):793-801. PubMed ID: 22829097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of quantitative diffusion-weighted imaging in characterization of hypovascular liver lesions: A prospective comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient.
    Kovač JD; Daković M; Janković A; Mitrović M; Dugalić V; Galun D; Đurić-Stefanović A; Mašulović D
    PLoS One; 2021; 16(2):e0247301. PubMed ID: 33606753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging predict microvascular invasion?
    Zhou Y; Wang X; Xu C; Zhou G; Liu X; Gao S; Xu P
    J Magn Reson Imaging; 2019 Jul; 50(1):315-324. PubMed ID: 30444023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
    Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
    Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of Gd-BOPTA- enhanced MRIs and DWI in the diagnosis of intrahepatic mass-forming cholangiocarcinoma.
    Xu CC; Tang YF; Ruan XZ; Huang QL; Sun L; Li J
    Neoplasma; 2017; 64(6):945-953. PubMed ID: 28895422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
    Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
    Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
    Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
    Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size.
    Ni T; Shang XS; Wang WT; Hu XX; Zeng MS; Rao SX
    Br J Radiol; 2018 Jul; 91(1088):20180017. PubMed ID: 29791202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI characteristics for the differential diagnosis of benign and malignant small solitary hypovascular hepatic nodules.
    Qian H; Li S; Ji M; Lin G
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):749-56. PubMed ID: 27104682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features.
    Shen K; Mo W; Wang X; Shi D; Qian W; Sun J; Yu R
    Eur Radiol; 2023 Dec; 33(12):8986-8998. PubMed ID: 37392232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.
    Kovač JD; Janković A; Đikić-Rom A; Grubor N; Antić A; Dugalić V
    Curr Oncol; 2022 Jan; 29(2):698-723. PubMed ID: 35200560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Hepatocellular Carcinoma.
    Zou X; Luo Y; Li Z; Hu Y; Li H; Tang H; Shen Y; Hu D; Kamel IR
    J Magn Reson Imaging; 2019 Apr; 49(4):975-983. PubMed ID: 30277628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peribiliary liver metastases MR findings.
    Granata V; Fusco R; Catalano O; Avallone A; Leongito M; Izzo F; Petrillo A
    Med Oncol; 2017 Jul; 34(7):124. PubMed ID: 28573638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma.
    Park MJ; Kim YK; Park HJ; Hwang J; Lee WJ
    J Comput Assist Tomogr; 2013; 37(6):872-81. PubMed ID: 24270108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted MRI of metastatic liver lesions: is there a difference between hypervascular and hypovascular metastases?
    Schmid-Tannwald C; Thomas S; Ivancevic MK; Dahi F; Rist C; Sethi I; Oto A
    Acta Radiol; 2014 Jun; 55(5):515-23. PubMed ID: 23986455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic and hilar mass-forming cholangiocarcinoma: Qualitative and quantitative evaluation with diffusion-weighted MR imaging.
    Fattach HE; Dohan A; Guerrache Y; Dautry R; Boudiaf M; Hoeffel C; Soyer P
    Eur J Radiol; 2015 Aug; 84(8):1444-1451. PubMed ID: 26022518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
    Chong YS; Kim YK; Lee MW; Kim SH; Lee WJ; Rhim HC; Lee SJ
    Clin Radiol; 2012 Aug; 67(8):766-73. PubMed ID: 22425613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase.
    Mamone G; Marrone G; Caruso S; Carollo V; Gentile G; Crino' F; Milazzo M; Luca A
    Abdom Imaging; 2015 Oct; 40(7):2313-22. PubMed ID: 25962708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.